Satish B Bhawsar

This inventor holds 17 USPTO granted patents, plus 3 CIPO patents and 3 EPO patents, primarily in Antibacterial Compounds. Top assignee: Wockhardt Limited. Active years: 2003-2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Satish B Bhawsar. Retrieved from https://idiyas.com/inventor/satish-b-bhawsar

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 17

% Patents Active = 17.6

CIPO Patents = 3 (Patent Applications = 2)

EPO Patents = 3 (Patent Applications = 5)

Average Co-Inventor Count = 8.7

ph-index = 4

Forward Citations = 89(Granted Patents)

Location History:

Chikaltana, IN (2003 - 2004)
Aurangabad, IN (2003 - 2017)

Company Filing History:

17 out of 117

Wockhardt Limited

patents

Years Active: 2003-2017

Loading Chart...

Areas of Expertise:

Antibacterial Agents

Nitrogen Compounds

Heterocyclic Compounds

Chiral Derivatives

Piperidine

Fluoroquinolone

Inhibitors

Cellular Efflux Pumps

Bacterial Infections

Diazabicyclo Compounds

Medicaments

17 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9834557 - Process for preparation of (2S, 5R)-7-oxo-6-sulphooxy-2-[((3R)-piperidine-3-carbonyl)-hydrazino carbonyl]-1,6-diaza-bicyclo [3.2.1]-octane (2017-12-05),

2. 9822115 - Nitrogen containing compounds and their use as antibacterial agents (2017-11-21),

3. 9771364 - Process for preparation of (2S,5R)-6-sulphooxy-7-oxo-2-[((3R)-piperidine-3-carbonyl)-hydrazinocarbonyl]-1,6-diaza-bicyclo[3.2.1] octane (2017-09-26),

4. 9657021 - Process for preparation of (2S, 5R)-7-oxo-6-sulphooxy-2[((3R)-piperidine-3-carbonyl)-hydrazino carbonyl]-1,6-diaza-bicyclo [3.2.1]-octane (2017-05-23),

5. 9624222 - Process for preparation of (2S, 5R)-7-oxo-6-sulphooxy-2-[((3R)-pyrrolidine-3-carbonyl)-hydrazino carbonyl]-1,6-diaza-bicyclo[3.2.1]octance (2017-04-18),

6. 9567335 - Process for sodium salt of (2S, 5R)-2-carboxamido-7-oxo-6-sulfooxy -1,6-diaza-bicyclo[3.2.1]octane (2017-02-14),

7. 9556174 - (2S, 5R)-sulfuric acid mono-{[(4-aminopiperidin-4-yl) carbonyl]-7-oxo-1,6-diaza-bicyclo[3.2.1]-oct-6-yl} ester (2017-01-31),

8. 9499544 - Nitrogen containing heterocyclic compounds (2016-11-22),

9. 9434728 - Nitrogen containing compounds and their use (2016-09-06),

10. 9127004 - Nitrogen containing heterocyclic compounds (2015-09-08),

11. 9006230 - 1,6-diazabicyclo [3,2,1] octan-7-one derivatives and their use in the treatment of bacterial infections (2015-04-14),

12. 8822450 - 1,6-diazabicyclo [3,2,1] octan-7-one derivatives and their use in the treatment of bacterial infections (2014-09-02),

13. 7098219 - Inhibitors of cellular efflux pumps of microbes (2006-08-29),

14. 6964966 - Generation triple-targeting, chiral, broad-spectrum antimicrobial 7-substituted piperidino-quinolone carboxylic acid derivatives, their preparation, compositions and use as medicaments (2005-11-15),

15. 6753333 - Chiral fluoroquinolone arginine salt forms (2004-06-22),

Title: Innovations and Contributions of Satish B Bhawsar

Introduction

Satish B Bhawsar is a notable inventor based in Chikaltana, India. He has made significant contributions to the field of chemistry, particularly in the development of novel compounds with antibacterial properties. With a total of 17 patents to his name, Bhawsar's work has had a considerable impact on pharmaceutical research and development.

Latest Patents

Among his latest patents is a process for the preparation of (2S, 5R)-7-oxo-6-sulphooxy-2-[((3R)-piperidine-3-carbonyl)-hydrazino carbonyl]-1,6-diaza-bicyclo[3.2.1]octane. This innovative process showcases his expertise in synthesizing complex chemical structures. Additionally, he has developed nitrogen-containing compounds and their use as antibacterial agents, which are crucial in preventing or treating bacterial infections.

Career Highlights

Throughout his career, Bhawsar has worked with prominent companies, including Wockhardt Limited. His experience in the pharmaceutical industry has allowed him to apply his inventive skills to real-world challenges, leading to the development of effective medical solutions.

Collaborations

Bhawsar has collaborated with notable colleagues such as Mahesh Vithalbhai Patel and Prasad Keshav Deshpande. These partnerships have fostered a collaborative environment that enhances innovation and drives research forward.

Conclusion

Satish B Bhawsar's contributions to the field of chemistry and his extensive patent portfolio highlight his role as a significant inventor. His work continues to influence the development of new antibacterial agents, showcasing the importance of innovation in healthcare.

Profile summary based on public USPTO records.